• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Circulating Antibodies Against DSG1 and DSG3 in Patients with Oral Lichen Planus: A Scoping Review.口腔扁平苔藓患者中抗桥粒芯糖蛋白1和桥粒芯糖蛋白3的循环抗体:一项范围综述
Antibodies (Basel). 2025 Jun 18;14(2):51. doi: 10.3390/antib14020051.
2
Interventions for treating oral lichen planus.治疗口腔扁平苔藓的干预措施。
Cochrane Database Syst Rev. 2011 Jul 6(7):CD001168. doi: 10.1002/14651858.CD001168.pub2.
3
Two cases of erosive oral lichen planus with autoantibodies to desmoglein 3.两例伴有桥粒芯糖蛋白3自身抗体的糜烂性口腔扁平苔藓。
J Dermatol. 2016 Nov;43(11):1350-1353. doi: 10.1111/1346-8138.13493. Epub 2016 Jul 26.
4
A Systematic Review of Interleukin-17 in Oral Lichen Planus: From Etiopathogenesis to Treatment.《口腔扁平苔藓中白细胞介素-17 的系统评价:从发病机制到治疗》。
Clin Med Res. 2023 Dec;21(4):201-215. doi: 10.3121/cmr.2023.1822.
5
Interventions for erosive lichen planus affecting mucosal sites.针对累及黏膜部位的糜烂性扁平苔藓的干预措施。
Cochrane Database Syst Rev. 2012 Feb 15;2012(2):CD008092. doi: 10.1002/14651858.CD008092.pub2.
6
Potential role of INTERLEUKIN-17 in the pathogenesis of oral lichen planus: a systematic review with META-analysis.白细胞介素-17 在口腔扁平苔藓发病机制中的潜在作用:系统评价与荟萃分析。
J Eur Acad Dermatol Venereol. 2022 Oct;36(10):1735-1744. doi: 10.1111/jdv.18219. Epub 2022 May 24.
7
Efficacy of Platelet-Rich Plasma Therapy in Oral Lichen Planus: A Systematic Review.富血小板血浆疗法治疗口腔扁平苔藓的疗效:系统评价。
Medicina (Kaunas). 2023 Apr 11;59(4):746. doi: 10.3390/medicina59040746.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.

本文引用的文献

1
Italian Consensus on the treatment of oral lichen planus.意大利口腔扁平苔藓治疗共识
Ital J Dermatol Venerol. 2025 Apr;160(2):83-96. doi: 10.23736/S2784-8671.25.08143-5.
2
Molecular Markers in Oral Lichen Planus - Insight into Pathogenesis.口腔扁平苔藓中的分子标志物——对发病机制的深入了解
Head Neck Pathol. 2025 Mar 26;19(1):38. doi: 10.1007/s12105-025-01775-1.
3
Clinical Features of Oral Lichen Planus: A Pictorial and Systematic Review.口腔扁平苔藓的临床特征:图文并茂的系统综述
Indian J Otolaryngol Head Neck Surg. 2025 Mar;77(3):1692-1697. doi: 10.1007/s12070-025-05337-3. Epub 2025 Jan 18.
4
Molecular Markers of Occult Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma (HNSCC) Patients.头颈部鳞状细胞癌(HNSCC)患者隐匿性淋巴结转移的分子标志物
Front Biosci (Landmark Ed). 2025 Feb 20;30(2):25267. doi: 10.31083/FBL25267.
5
"Exploring the Link Between Oral Lichen Planus and Xerostomia: A Systematic Literature Review".探索扁平苔藓与口干症之间的联系:一项系统的文献综述
Immun Inflamm Dis. 2024 Dec;12(12):e70101. doi: 10.1002/iid3.70101.
6
Malignant transformation of oral lichen planus: where are we now?口腔扁平苔藓的恶性转化:我们目前的进展如何?
Med Oral Patol Oral Cir Bucal. 2025 Jan 1;30(1):e65-e75. doi: 10.4317/medoral.26834.
7
Evaluation of the Role of Oral Microbes in Pathogenesis of Oral Lichen Planus.口腔微生物在口腔扁平苔藓发病机制中的作用评估
J Pharm Bioallied Sci. 2024 Jul;16(Suppl 3):S2153-S2155. doi: 10.4103/jpbs.jpbs_90_24. Epub 2024 Apr 24.
8
Oral Lichen Planus: A Narrative Review Navigating Etiologies, Clinical Manifestations, Diagnostics, and Therapeutic Approaches.口腔扁平苔藓:一篇关于病因、临床表现、诊断及治疗方法的叙述性综述
J Clin Med. 2024 Sep 5;13(17):5280. doi: 10.3390/jcm13175280.
9
Pathogenic relevance of antibodies against desmoglein 3 in patients with oral lichen planus.抗桥粒芯糖蛋白 3 抗体在口腔扁平苔藓患者中的致病性相关性。
J Dtsch Dermatol Ges. 2024 Oct;22(10):1392-1399. doi: 10.1111/ddg.15510. Epub 2024 Aug 16.
10
Hepatitis C Virus (HCV) Infection: Pathogenesis, Oral Manifestations, and the Role of Direct-Acting Antiviral Therapy: A Narrative Review.丙型肝炎病毒(HCV)感染:发病机制、口腔表现及直接抗病毒治疗的作用:一项叙述性综述
J Clin Med. 2024 Jul 9;13(14):4012. doi: 10.3390/jcm13144012.

口腔扁平苔藓患者中抗桥粒芯糖蛋白1和桥粒芯糖蛋白3的循环抗体:一项范围综述

Circulating Antibodies Against DSG1 and DSG3 in Patients with Oral Lichen Planus: A Scoping Review.

作者信息

De Falco Domenico, Iaquinta Francesca, Pedone Doriana, Lucchese Alberta, Di Stasio Dario, Petruzzi Massimo

机构信息

Interdisciplinary Department of Medicine, University of Bari, 70121 Bari, Italy.

Multidisciplinary Department of Medical and Dental Specialties, University of Campania-"Luigi Vanvitelli", Via L. De Crecchio, 6, 80138 Naples, Italy.

出版信息

Antibodies (Basel). 2025 Jun 18;14(2):51. doi: 10.3390/antib14020051.

DOI:10.3390/antib14020051
PMID:40558105
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12189673/
Abstract

Oral Lichen Planus (OLP) is a chronic autoimmune disease with potential overlap with Pemphigus Vulgaris (PV), particularly in erosive forms. Desmoglein 1 and 3 are transmembrane glycoproteins of desmosomes, typically involved in PV. This scoping review aims to evaluate the presence and potential pathogenetic role of anti-desmoglein 1 (Dsg1) and anti-desmoglein 3 (Dsg3) antibodies in OLP. A literature search was conducted on MEDLINE/PubMed, Ovid, and Scopus up to April 2025. Human studies reporting OLP patients with anti-Dsg1 and/or anti-Dsg3 antibodies were included. Data from 11 studies were analyzed by diagnosis, age/sex, oral site involvement, immunofluorescence, and ELISA testing. Erosive OLP was most frequently associated with anti-Dsg1/Dsg3 positivity, mainly in women aged 40-60. Immunofluorescence was positive in some cases, while the ELISA test almost consistently detected anti-Dsg1 and Dsg3 antibodies. However, in many instances, antibody titers did not reach the threshold value, despite the presence being detectable. This finding suggests that anti-Dsg1/Dsg3 antibodies may represent epiphenomena of chronic inflammation in erosive OLP, indicating an immune-serological overlap with PV but lacking direct pathogenicity. Furthermore, the role of Dsg3 in oral squamous cell carcinoma, by promoting enzymes that degrade the extracellular matrix and enhance tumor invasiveness, highlights the complex functions of desmogleins beyond autoimmunity.

摘要

口腔扁平苔藓(OLP)是一种慢性自身免疫性疾病,与寻常型天疱疮(PV)可能存在重叠,尤其是糜烂型。桥粒芯糖蛋白1和3是桥粒的跨膜糖蛋白,通常与PV有关。本综述旨在评估抗桥粒芯糖蛋白1(Dsg1)和抗桥粒芯糖蛋白3(Dsg3)抗体在OLP中的存在情况及其潜在的致病作用。截至2025年4月,在MEDLINE/PubMed、Ovid和Scopus上进行了文献检索。纳入了报告OLP患者存在抗Dsg1和/或抗Dsg3抗体的人体研究。对11项研究的数据按诊断、年龄/性别、口腔受累部位、免疫荧光和酶联免疫吸附测定(ELISA)检测进行了分析。糜烂型OLP最常与抗Dsg1/Dsg3阳性相关,主要见于40至60岁的女性。免疫荧光在某些情况下呈阳性,而ELISA检测几乎始终能检测到抗Dsg1和Dsg3抗体。然而,在许多情况下,尽管抗体滴度可检测到,但未达到阈值。这一发现表明,抗Dsg1/Dsg3抗体可能是糜烂型OLP慢性炎症的附带现象,表明与PV存在免疫血清学重叠,但缺乏直接致病性。此外,Dsg3通过促进降解细胞外基质并增强肿瘤侵袭性的酶的作用,在口腔鳞状细胞癌中的作用突出了桥粒芯糖蛋白在自身免疫之外的复杂功能。